Clinical Trials Directory

Trials / Unknown

UnknownNCT02859571

Continuous Versus Intermittent Oxytocin for Induction of Labor: A Randomized Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study evaluates continuous oxytocin versus intermittent oxytocin for induction of labor at term. Half of participants will be taken continuous oxytocin, while the other half will be taken intermittent oxytocin.

Detailed description

In the continuous oxytocin group, traditional treatment of oxytocin used at a starting dose of 1-2 mIU/min and the dose was increased by 2 mIU/min at every 15 minutes until regular contractions obtained at a rate of 3-5 contractions in a 10-minute period. The maximum dose of oxytocin was 40 mIU/min and oxytocin was administered until delivery. In the intermittent group, oxytocin was discontinued when cervical dilation was 5 cm and 2 hours after discontinuation oxytocin was reused at a starting dose of 1-2 mIU/min and was increased as the same protocol used for continuation oxytocin group.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin

Timeline

Start date
2016-08-01
Primary completion
2016-12-01
Completion
2017-01-01
First posted
2016-08-09
Last updated
2016-12-08

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02859571. Inclusion in this directory is not an endorsement.